An Overview of the Dry Eye Disease in Sjögren's Syndrome Using Our Current Molecular Understanding

KY Wu, M Kulbay, C Tanasescu, B Jiao… - International Journal of …, 2023 - mdpi.com
Sjögren's syndrome is a chronic and insidious auto-immune disease characterized by
lymphocyte infiltration of exocrine glands. The patients typically present with ocular surface …

The involvement of innate and adaptive immunity in the initiation and perpetuation of sjögren's syndrome

C Chivasso, J Sarrand, J Perret, C Delporte… - International journal of …, 2021 - mdpi.com
Sjogren's syndrome (SS) is a chronic autoimmune disease characterized by the infiltration of
exocrine glands including salivary and lachrymal glands responsible for the classical dry …

A new molecular classification to drive precision treatment strategies in primary Sjögren's syndrome

P Soret, C Le Dantec, E Desvaux, N Foulquier… - Nature …, 2021 - nature.com
There is currently no approved treatment for primary Sjögren's syndrome, a disease that
primarily affects adult women. The difficulty in developing effective therapies is-in part …

Leflunomide–hydroxychloroquine combination therapy in patients with primary Sjögren's syndrome (RepurpSS-I): a placebo-controlled, double-blinded, randomised …

EHM van der Heijden, SLM Blokland… - The Lancet …, 2020 - thelancet.com
Summary Background Primary Sjögren's syndrome is a systemic autoimmune disease
characterised by secretory gland dysfunction, for which no effective therapy is available …

[PDF][PDF] One year in review 2020: pathogenesis of primary Sjögren's syndrome

M Bombardieri, OD Argyropoulou, F Ferro… - Clin Exp …, 2020 - clinexprheumatol.org
The pathogenesis of primary Sjögren's syndrome (pSS) remains poorly understood.
However, important efforts have been made during the last few months. In this review …

Plasmacytoid dendritic cells in the eye

A Jamali, B Kenyon, G Ortiz, A Abou-Slaybi… - Progress in retinal and …, 2021 - Elsevier
Plasmacytoid dendritic cells (pDCs) are a unique subpopulation of immune cells, distinct
from classical dendritic cells. pDCs are generated in the bone marrow and following …

Type I interferon pathway assays in studies of rheumatic and musculoskeletal diseases: a systematic literature review informing EULAR points to consider

A Burska, J Rodríguez-Carrio, R Biesen, WA Dik… - RMD open, 2023 - rmdopen.bmj.com
Objectives To systematically review the literature for assay methods that aim to evaluate type
I interferon (IFN-I) pathway activation and to harmonise-related terminology. Methods Three …

Early diagnosis and treatment for Sjögren's syndrome: current challenges, redefined disease stages and future prospects

B Wang, S Chen, Q Zheng, Y Li, X Zhang, J Xuan… - Journal of …, 2021 - Elsevier
There are some challenges and unmet needs in the early diagnosis and management of
Sjögren's syndrome (SjS) such as prominent glandular dysfunction at diagnosis and long …

Transcriptomic and network analysis of minor salivary glands of patients with primary Sjögren's syndrome

A Oyelakin, E Horeth, EAC Song, S Min, M Che… - Frontiers in …, 2021 - frontiersin.org
Primary Sjögren's syndrome (pSS) is a systemic autoimmune disease characterized
primarily by immune-mediated destruction of exocrine tissues, such as those of the salivary …

The spectrum of extraglandular manifestations in primary sjögren's syndrome

A Mihai, C Caruntu, C Jurcut, FC Blajut… - Journal of Personalized …, 2023 - mdpi.com
Extraglandular manifestations (EGMs) in primary Sjogren's syndrome (pSS) represent the
clinical expression of the systemic involvement in this disease. EGMs are characterized by a …